<table border="0" cellpadding="0" cellspacing="0" id="ifb2e95b5-d5d0-47f2-8f52-3d8664a15546" width="597" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>
                Table 5: Results of Drug Interaction Studies with Stavudine: Effects of
                Coadministered Drug on Stavudine Plasma AUC and C<sub>max</sub>
                Values
              </caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th>Drug</th>
<th>
                    Stavudine<br/>  Dosage
                  </th>
<th>
                    n<sup>a   </sup>
</th>
<th>
                    AUC of<br/>Stavudine<br/> (95% CI)
                  </th>
<th>
                    C<sub>max</sub>
                    of<br/> Stavudine<br/>(95% CI)
                  </th>
</tr>
</thead>
<tbody>
<tr>
<td>
                    ↑ indicates increase<br/>↔ indicates no change, or mean increase or
                    decrease of greater then 10%.<br/>
<sup>a</sup> HIV-infected
                    patients.<br/>
</td>
</tr>
</tbody>
<tbody>
<tr>
<td>
                    Didanosine, 100 mg<br/>q12h for 4 days<br/>
</td>
<td>
                    40 mg q12h<br/>for 4 days<br/>
</td>
<td>
                    10   <br/>
</td>
<td>
                    ↔<br/>
</td>
<td>
                    ↑17%<br/>
</td>
</tr>
<tr>
<td>
                    Lamivudine, 150 mg<br/>single dose<br/>
</td>
<td>
                    40 mg single dose<br/>
</td>
<td>
                    18   <br/>
</td>
<td>
                    ↔<br/>(92.7-100.6%)<br/>
</td>
<td>
                    ↑12%<br/>(100.3-126.1%)<br/>
</td>
</tr>
<tr>
<td>
                    Nelfinavir, 750 mg<br/>q8h for 56 days<br/>
</td>
<td>
                    30 to 40 mg q12h<br/>for 56 days<br/>
</td>
<td>
                    8   <br/>
</td>
<td>
                    ↔<br/>
</td>
<td>
                    ↔<br/>
</td>
</tr>
</tbody>
</table>